REBEKAH BLAIR: Open Payments
NPI 1487396750 · JACKSBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$468 in 24 payments from 11 companies in 2025. Trend: 2023 $23 · 2024 $622 · 2025 $468
Food & beverage: $419Education: $49
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $85 |
| Novo Nordisk Inc | 4 | $81 |
| ABBVIE INC. | 3 | $62 |
| Axsome Therapeutics, Inc. | 4 | $62 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| Exact Sciences Corporation | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Abbott Laboratories | 1 | $17 |
| Organon LLC | 1 | $16 |
Products named: MOUNJARO, Auvelity, CAPLYTA, VRAYLAR, Kerendia, Wegovy, Ozempic, The Cologuard Plus Collection Kit.
Industry payments across TN — which companies pay providers there.
